North Carolina Research Campus, Human Performance Laboratory, Kannapolis, NC 28081, USA.
Appl Physiol Nutr Metab. 2011 Jun;36(3):331-8. doi: 10.1139/h11-015. Epub 2011 May 16.
In vitro and animal data suggest that quercetin affects adipogenesis and basal metabolism; however, whether this metabolic effect translates to reductions in body mass or improvement in body composition in humans is unknown. This study investigated 12-week supplementation of 2 different doses of quercetin, combined with vitamin C and niacin, on body mass and composition in a large, heterogeneous group of adults (n = 941; 60% female, 40% male; 18-85 years of age; 45% normal body mass index, 30% overweight, 25% obese). Subjects were randomized into 3 groups, with supplements administered in double-blind fashion: Q500 = 500 mg quercetin·day(-1), Q1000 = 1000 mg quercetin·day(-1), and placebo. Quercetin supplements were consumed twice daily over a 12-week period, and pre- and poststudy body mass and composition measurements were taken in an overnight fasted state. A general linear model was used to predict change in body mass and composition across groups with adjustment for demographic and lifestyle factors. Plasma quercetin increased in a dose-responsive manner in both Q500 and Q1000 groups relative to placebo. After adjustment for confounders, no significant differences in body mass (males interaction p value = 0.721, females p = 0.366) or body composition (males p = 0.650, females p = 0.639) were found between Q500 or Q1000 groups compared with placebo. No group differences in body mass or body composition were found in a subgroup of overweight and obese subjects. High-dose quercetin supplementation (500 and 1000 mg·day(-1)) for 12 weeks in a large, heterogeneous group of adults did not affect body mass or composition.
体外和动物数据表明槲皮素会影响脂肪生成和基础代谢;然而,这种代谢作用是否能转化为体重减轻或改善人体成分尚不清楚。本研究调查了 12 周补充两种不同剂量的槲皮素,与维生素 C 和烟酸联合使用,对 941 名成年人(60%为女性,40%为男性;年龄 18-85 岁;45%为正常体重指数,30%为超重,25%为肥胖)的体重和成分的影响。受试者随机分为 3 组,以双盲方式给药:Q500 = 500mg 槲皮素/天,Q1000 = 1000mg 槲皮素/天,安慰剂。12 周期间每天两次服用槲皮素补充剂,在禁食过夜的状态下进行研究前后的体重和成分测量。使用一般线性模型预测各组体重和成分的变化,同时调整人口统计学和生活方式因素。与安慰剂相比,Q500 和 Q1000 组的血浆槲皮素呈剂量依赖性增加。在调整混杂因素后,Q500 或 Q1000 组与安慰剂相比,体重(男性交互 p 值=0.721,女性 p=0.366)或身体成分(男性 p=0.650,女性 p=0.639)均无显著差异。在超重和肥胖受试者的亚组中,也没有发现体重或身体成分的组间差异。在一个大型异质成年人群中,12 周内高剂量(500 和 1000mg/天)槲皮素补充剂并未影响体重或成分。